Drug Discovery

Historic challenges in ADC Development have not thwarted some players

The Drugs for Neglected Diseases initiative has a new leader – and he’s on a mission to redefine global health for an egalitarian, postcolonial world

AMR remains a pressing issue, but hydroquinine has yielded some interesting effects on clinically important bacteria

Insights into the quest to find an effective treatment for this socially painful condition

How global collaborations are inching us toward a victory over a neglected parasitic disease

Can AI usher in a new age of medicine or is it all hype? In this blog, we go down the rabbit hole.

As new treatment modalities emerge, drug developers are turning to synthetic chemistry – and partners like Veranova.

How two rival projects relate to a modern disease landscape threatened by climate change and low vaccination rates

What role must pharma play to help improve outcomes for women?

Based in Barcelona and Belgium, this startup company is bringing small molecules to the fight against X-linked leukodystrophy